Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis.

Amrutkar, Manoj; Berg, Kjersti; Balto, Aina; Skilbrei, Miguel G; Finstadsveen, Anette V; Aasrum, Monica; Gladhaug, Ivar P; Verbeke, Caroline S.

Afiliação

Amrutkar M; Department of Pathology, Oslo University Hospital Rikshospitalet, Oslo, Norway. manoj.amrutkar@medisin.uio.no.
Berg K; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. manoj.amrutkar@medisin.uio.no.
Balto A; Department of Pathology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Skilbrei MG; Department of Pathology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Finstadsveen AV; Department of Pathology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Aasrum M; Department of Pathology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Gladhaug IP; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Verbeke CS; Department of Hepato-Pancreato-Biliary Surgery, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Cancer Cell Int ; 23(1): 9, 2023 Jan 19.

Article em En | MEDLINE | ID: mdl-36658582